Production (Stage)
XBiotech Inc.
XBIT
$2.84
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 108.31% | 19.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 54.89% | 10.68% | |||
| Operating Income | -54.89% | -10.68% | |||
| Income Before Tax | -2.90% | -110.73% | |||
| Income Tax Expenses | 170.73% | -555.56% | |||
| Earnings from Continuing Operations | -3.58% | -109.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.58% | -109.53% | |||
| EBIT | -54.89% | -10.68% | |||
| EBITDA | -57.76% | -11.31% | |||
| EPS Basic | -3.51% | -109.54% | |||
| Normalized Basic EPS | -2.82% | -110.71% | |||
| EPS Diluted | -3.51% | -109.54% | |||
| Normalized Diluted EPS | -2.82% | -110.71% | |||
| Average Basic Shares Outstanding | 0.07% | -0.02% | |||
| Average Diluted Shares Outstanding | 0.07% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||